Concord Drugs Limited - Company Profile

It is a pharma public limited company based in Na, Telangana, India, established in 1995.
1995 Na, Telangana, India Active
Last Updated:
Access Report
About Concord Drugs Limited

Concord Drugs Limited, a active public limited company, was established on 24 April 1995 in Na, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24230TG1995PLC020093. Registered under ROC Roc Hyderabad. it is listed on BSE: 538965. It has an authorized capital of ₹15.50 Cr and a paid-up capital of ₹13.18 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹43.27 Cr and a net worth of ₹33.82 Cr. Employing 20 professional, Its leadership includes Namratha (Company Secretary), Nagi Reddy Seelam (Managing Director), Seelam Manojkumarreddy (Whole-Time Director). Past directors included Chandra Kala Panthamvar, Aakanksha, Nagi Reddy Seelam. It holds ₹18.25 Cr open charges and ₹7.40 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No.249, Brahmanapally Village Hayatnagar Mandal R.R.D Ist-501511, Na, Telangana.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24230TG1995PLC020093

  • Registration Number

    020093

  • Incorporation Date

    24 April 1995

  • Authorized Capital

    ₹15.50 Cr

  • Paid-Up Capital

    ₹13.18 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Listed (BSE: 538965)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.50 Cr
  • Paid Up Capital ₹ 13.18 Cr
  • Company Age 30 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 18.25 Cr
  • Satisfied Charges ₹ 7.40 Cr
Company report

Concord Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Concord Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Concord Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Namratha Company Secretary 19 Mar 2024 Current
Nagi Reddy Seelam Managing Director 04 Apr 2003 Current
Seelam Manojkumarreddy Whole-Time Director 13 Aug 2021 Current
Ramchandra Reddy Kommula Director 30 Mar 2019 Current
Nagavenkatahareeshkumar Solleti Director 13 Feb 2021 Current
Sumeela Kasu Director 01 Jun 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 01 Jun 2022 Past
Pramod Abcsdd Company Secretary 16 Nov 2017 Past
Pramod Abcsdd Whole-Time Director 13 Aug 2021 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Concord Drugs.

Concord Drugs Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Concord Drugs revenue growth over time
Concord Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Concord Drugs?

In 2023, Concord Drugs had a promoter holding of 52.13% and a public holding of 47.87%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹182,500,000.00

Satisfied Charges

₹74,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 18.25 Cr
Latest Charge Details
Date Lender Amount Status
17 Dec 2011 State Bank Of India ₹18.25 Cr Open
11 Mar 2022 Others ₹5.00 Cr Satisfied
10 Nov 2005 Punjab National Bank ₹1.40 Cr Satisfied
01 Jan 1998 Small Industries Development Bank Of India ₹5.00 M Satisfied
17 Oct 1997 Small Industries Development Bank Of India ₹5.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Concord Drugs?

Concord Drugs has a workforce of 20 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Concord Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Concord Drugs
Recent Activity within the Organization
  • Director Appointment

    Progress on Satyam Reddy Gopidi was appointed as a Director was appointed as a Director on 30 Sep 2025 & has been associated with this company since 5 months 4 days . was documented.

  • Annual General Meeting

    Concord Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 18.25 Cr registered on 17 Dec 2011 with Charge ID 10394597 was modified on 31 Jul 2024. was documented.

  • Director Appointment

    The activity Namratha was appointed as a Company Secretary was appointed as a Company Secretary on 08 Apr 2024 & has been associated with this company since 1 year 10 months . was completed.

  • Balance Sheet

    The activity Concord Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Director Appointment

    Namratha was appointed as a Company Secretary was appointed as a Company Secretary on 19 Mar 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Concord Drugs Limited?

The CIN of Concord Drugs Limited is L24230TG1995PLC020093.

Where is Concord Drugs Limited headquartered?

Concord Drugs Limited is headquartered at Survey No.249, Brahmanapally Village Hayatnagar Mandal R.R.D Ist-501511, Na, Telangana.

When was Concord Drugs Limited incorporated?

Concord Drugs Limited was incorporated on 24 April 1995.

Who are the current directors of Concord Drugs Limited?

The current directors of Concord Drugs Limited are

What is the primary industry of Concord Drugs Limited?

The primary industry of Concord Drugs Limited is Manufacturing.

Is Concord Drugs Limited a listed company?

Concord Drugs Limited is listed. It is listed on BSE: 538965.

What is the capital structure of Concord Drugs Limited?

The authorized capital of Concord Drugs Limited is ₹15.50 Cr, and the paid-up capital is ₹13.18 Cr.

What is the compliance status of Concord Drugs Limited?

The compliance status of Concord Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available